A decade of chronic lymphocytic leukaemia therapy in Germany: Real‐world treatment patterns and outcomes (2010–2022)

Documenti analoghi

• Uptake of the first to fifth doses of coronavirus disease 2019 vaccine in individuals with chronic lymphocytic leukaemia: A nationwide cohort study in Sweden
  di: Pontus Hedberg, et al.
  Pubblicazione: (2025)
• Pneumonia in patients with chronic lymphocytic leukemia treated with venetoclax‐based regimens: A real‐world analysis of Polish Adult Leukemia Group (PALG)
  di: Elżbieta Kalicińska, et al.
  Pubblicazione: (2024)
• Medical history and lifestyle factors have limited impact on time‐to‐first‐treatment in patients with chronic lymphocytic leukemia
  di: Ingrid Glimelius, et al.
  Pubblicazione: (2024)
• Real‐world characteristics and outcomes of patients with multiple myeloma receiving second‐line treatment in England
  di: Sally Moore, et al.
  Pubblicazione: (2024)
• Establishing meaningful change thresholds for European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire CLL‐specific module domain scores: An analysis based on the TRANSCEND CLL 004 study in patients with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma
  di: Laurie Eliason, et al.
  Pubblicazione: (2024)